Early-Stage HCC Percutaneous Locoregional Management: East versus West Perspectives.
Roberto IezziAlessandro PosaAndrea ContegiacomoIn Joon LeeReto BaleAlessandro TanzilliLorenzo TenoreFelice GiulianteAntonio GasbarriniShraga Nahum GoldbergTobias JakobsMaurizio PompiliIrene BargelliniEvis SalaHyo-Cheol KimPublished in: Cancers (2023)
Hepatocellular carcinoma represents an important cause of death worldwide. Early-stage hepatocellular carcinoma patients not suitable for surgery can be treated with a variety of minimally invasive locoregional interventional oncology techniques. Various guidelines in different countries address the treatment of hepatocellular carcinoma, but the actual treatment is usually discussed by a multidisciplinary tumor board in a personalized manner, leading to potential treatment differences based on Western and Eastern perspectives. The aim of this paper is to integrate literature evidence with the eminent experiences collected during a focused session at the Mediterranean Interventional Oncology (MIO) Live Congress 2023.
Keyphrases
- minimally invasive
- early stage
- end stage renal disease
- systematic review
- chronic kidney disease
- palliative care
- newly diagnosed
- mental health
- peritoneal dialysis
- coronary artery disease
- risk assessment
- radiation therapy
- lymph node
- quality improvement
- combination therapy
- robot assisted
- neoadjuvant chemotherapy
- smoking cessation
- working memory